Importantly, competitive blocking with excess folic acid or EC20 was utilized in multiple models, which confirmed target specificity and temporary receptor saturation in normal tissues, particularly renal FR-α, can reduce retention of the kidney without significantly tumor accumulation effect. Here, FOLR1 is linked to neoplasm.